IO BIOTECH INC (IOBT) Stock Balance Sheet
NASDAQ:IOBT - Nasdaq - US4497781090 - Common Stock - Currency: USD
| MRQ (2025-3-31) | 2023 (2023-12-31) | 2022 (2022-12-31) | 2021 (2021-12-31) | 2020 (2020-12-31) | ||||
|---|---|---|---|---|---|---|---|---|
| ASSETS | ||||||||
| Current Assets | ||||||||
| Cash Equivalents | 37.09M | 143.19M | 142.60M | 211.50M | 3.40M | |||
| Receivables | 922.00K | 1.13M | 1.50M | 2.10M | 1.50M | |||
| Other Current Assets | 4.33M | 2.94M | 4.10M | 8.10M | 700.00K | |||
| Total Current Assets | 42.34M | 147.25M | 148.20M | 221.70M | 5.60M | |||
| Non-Current Assets | ||||||||
| PPE Net | 2.20M | 3.11M | 3.20M | N/A | N/A | |||
| Other Non-Current Assets | 1.19M | 357.00K | 400.00K | 600.00K | 0.00 | |||
| Total Non-Current Assets | 3.39M | 3.46M | 3.60M | 600.00K | 100.00K | |||
| TOTAL ASSETS | 45.74M | 150.72M | 151.80M | 222.30M | 5.70M | |||
| LIABILITIES | ||||||||
| Current Liabilities | ||||||||
| Short Term Debt | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |||
| Accrued Expenses | 11.91M | 11.03M | 4.30M | 5.90M | 2.50M | |||
| Accounts Payable | 5.20M | 3.88M | 4.00M | 3.90M | 500.00K | |||
| Other Current Liabilities | 1.17M | 806.00K | 2.40M | 500.00K | 0.00 | |||
| Total Current Liabilities | 18.29M | 15.72M | 10.70M | 10.30M | 3.10M | |||
| Non-Current Liabilities | ||||||||
| Long Term Debt | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |||
| Other Non-Current Liabilities | 1.03M | 1.84M | 2.30M | 100.00K | 0.00 | |||
| Total Non-Current Liabilities | 1.03M | 1.84M | 2.30M | 100.00K | 0.00 | |||
| TOTAL LIABILITIES | 19.31M | 17.56M | 13.00M | 10.40M | 3.10M | |||
| SHAREHOLDERS' EQUITY | ||||||||
| Retained Earnings | -381.73M | -263.82M | -177.70M | -106.30M | -38.40M | |||
| Additional Paid In Capital | 414.68M | 406.59M | 326.70M | 319.70M | 1.10M | |||
| Common Shares | 66.00K | 66.00K | 0.00 | 0.00 | 37.90M | |||
| Other Shareholders' Equity | -6.59M | -9.67M | -10.10M | -1.50M | 2.00M | |||
| Shares Outstanding | 65.88M | 65.88M | 28.80M | 28.80M | 27.70M | |||
| Tangible Book Value per Share | 0.40 | 2.02 | 4.82 | 7.36 | -1.27 | |||
| Total Shareholders' Equity | 26.42M | 133.16M | 138.90M | 211.90M | 2.60M | |||
| TOTAL LIABILITIES AND EQUITY | 45.74M | 150.72M | 151.80M | 222.30M | 5.70M | |||
| Statistics | ||||||||
| Current Ratio | 2.32 | 9.37 | 13.85 | 21.52 | 1.81 | |||
| Return On Assets (ROA) | -215.27% | -57.12% | -47.08% | -33.73% | -255.96% | |||
| Return On Equity (ROE) | -372.63% | -64.65% | -51.45% | -35.39% | -561.15% | |||
All data in USD , ROIC based on taxRate of 0.21